BXP-9

N/A

Report date: 2025/10/27 13:57:07
NME

Base Information

Drug NameBXP-9
Drug Alias NameKhaldi-K19Hchalocidin analog (BexCore)antimicrobial peptide (BexCore)BXP-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUlcerCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBexCore Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesBexCore Co Ltd
Active IndicationsUlcer
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A